SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 607 filers reported holding SEAGEN INC in Q3 2023. The put-call ratio across all filers is 3.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $712,698,407 | +11.1% | 3,359,408 | +0.8% | 0.04% | +17.6% |
Q2 2023 | $641,700,902 | -5.5% | 3,334,204 | -0.6% | 0.03% | -10.5% |
Q1 2023 | $679,131,416 | -25.5% | 3,354,232 | -52.7% | 0.04% | +40.7% |
Q4 2022 | $911,612,158 | +92.8% | 7,093,706 | +105.3% | 0.03% | -10.0% |
Q3 2022 | $472,875,000 | -22.6% | 3,455,933 | +0.1% | 0.03% | -18.9% |
Q2 2022 | $611,137,000 | +20.3% | 3,453,924 | -2.0% | 0.04% | +48.0% |
Q1 2022 | $507,835,000 | -6.2% | 3,525,411 | +0.7% | 0.02% | -3.8% |
Q4 2021 | $541,186,000 | -3.9% | 3,500,558 | +5.6% | 0.03% | -13.3% |
Q3 2021 | $562,966,000 | +10.9% | 3,315,465 | +3.1% | 0.03% | +11.1% |
Q2 2021 | $507,845,000 | +25.5% | 3,216,653 | +10.4% | 0.03% | +17.4% |
Q1 2021 | $404,667,000 | -21.4% | 2,914,205 | -0.8% | 0.02% | -28.1% |
Q4 2020 | $514,552,000 | – | 2,937,945 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |